Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$7.06 USD
-0.10 (-1.40%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $7.07 +0.01 (0.14%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
NUS 7.06 -0.10(-1.40%)
Will NUS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NUS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NUS
NUS Stock Hurt by Customer Acquisition Challenges: How to Play Ahead?
Nu Skin (NUS) Down 28% in 3 Months: What's the Next Best Move?
NUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Options Traders Betting on a Big Move in Nu Skin (NUS) Stock?
Nu Skin (NUS) Trims FY24 View Despite Q2 Earnings Beat
Nu Skin Enterprises (NUS) Q2 Earnings and Revenues Surpass Estimates
Other News for NUS
Nu Skin Enterprises Appoints Mark A. Zorko to Board of Directors
Nu Skin Expands Board with Mark Zorko’s Appointment
Nu Skin names Mark Zorko to board of directors
CNH Industrial, Parsons and more join S&P MidCap 400
Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600